SCHEMBL3665414

SCHEMBL3665414

O=C(NC1CCN(Cc2cccnc2)C(I)C1)c1cncc(OC2CCN(c3ccc(C(F)(F)F)cc3)CC2)c1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A5 Q9Y345 3/20 0.50
DRD4 P21917 3/20 0.41
SSTR5 P35346 1/20 0.40
HIF1A Q16665 5/20 0.40
EPAS1 Q99814 5/20 0.40
KCNH2 Q12809 3/20 0.40
MCHR1 Q99705 2/20 0.40
CXCR4 P61073 1/20 0.40
PRMT5 O14744 1/20 0.38
WDR77 Q9BQA1 1/20 0.38
FFAR1 O14842 1/20 0.38
DRD2 P14416 1/20 0.37
OPRM1 P35372 1/20 0.37
OPRK1 P41145 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3666588 0.93 SSTR5 (0.42) SLC6A5DRD4SSTR5PRMT5WDR77
SCHEMBL649468 0.89 SLC6A5 (0.64) SLC6A5DRD4SSTR5HIF1AEPAS1
SCHEMBL3662808 0.88 PRKAA2 (0.46) SLC6A5SSTR5
SCHEMBL3798034 0.88 SLC6A5 (0.50) SLC6A5HIF1AEPAS1KCNH2MCHR1
SCHEMBL3662664 0.86 SLC6A5 (0.46) SLC6A5DRD4HIF1AEPAS1KCNH2
SCHEMBL4441003 0.86 DRD4 (0.43) SLC6A5DRD4KCNH2DRD2OPRM1
SCHEMBL3668577 0.85 SLC6A5 (0.45) SLC6A5DRD4HIF1AEPAS1KCNH2
SCHEMBL649704 0.81 SSTR5 (0.54) SLC6A5DRD4SSTR5HIF1AEPAS1
SCHEMBL3661407 0.80 SLC6A5 (0.42) SLC6A5DRD4HIF1AEPAS1DRD2
SCHEMBL3660163 0.80 F10 (0.39) SLC6A5DRD4KCNH2OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231600-A1 CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS Rigel Pharmaceuticals, Inc. (US) 2010-09-29 EP claimed
WO-2009065131-A1 CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS RIGEL PHARMACEUTICALS, INC. (US) 2009-05-22 WO claimed